(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.01%) $78.37
(0.59%) $2.22
(-0.06%) $2 322.80
(-0.25%) $27.48
(0.09%) $989.30
(0.08%) $0.930
(0.15%) $10.92
(0.06%) $0.800
(0.12%) $91.45
1.82% KRW 785 000
Live Chart Being Loaded With Signals
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO)...
Stats | |
---|---|
Dzisiejszy wolumen | 0.00 |
Średni wolumen | 62 854.00 |
Kapitalizacja rynkowa | 55 871.59B |
EPS | KRW0 ( 2024-04-24 ) |
Następna data zysków | ( KRW2 823.26 ) 2024-07-24 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW1 109.05 (0.14%) |
Wolumen Korelacja
Samsung Biologics Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Samsung Biologics Korelacja - Waluta/Towar
Samsung Biologics Finanse
Annual | 2023 |
Przychody: | KRW3 694.59B |
Zysk brutto: | KRW1 802.76B (48.79 %) |
EPS: | KRW12 050 |
FY | 2023 |
Przychody: | KRW3 694.59B |
Zysk brutto: | KRW1 802.76B (48.79 %) |
EPS: | KRW12 050 |
FY | 2022 |
Przychody: | KRW3 001.30B |
Zysk brutto: | KRW1 468.45B (48.93 %) |
EPS: | KRW11 442 |
FY | 2021 |
Przychody: | KRW1 568.01B |
Zysk brutto: | KRW726.45B (46.33 %) |
EPS: | KRW5 948.61 |
Financial Reports:
No articles found.
Samsung Biologics
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej